Securities Law

A devastating congressional report has triggered a class action against Webull, exposing the severe risks of masking Chinese operations as American fintech.

CrowdStrike’s latest battle with an offshore LLC highlights the hidden dangers of mini-tender offers and the regulatory gaps threatening retail investors.

A proposed $38.25 million class action settlement exposes the perils of pre-COVID fixed-price contracts, but CAE's insurance strategy limits the damage.

Dinari and Kakaopay Securities are bypassing legacy market friction to bring South Korean equities to the blockchain. Will this cure the Korea Discount?

With the SEC turning minor tagging errors into automated filing suspensions, small-cap issuers must embrace parallel processing and legal ethics to survive.

As markets grow more complex, a new breed of investigators offers corporate boards a powerful tool: data-driven analysis to combat speculation and manipulation.

A late SEC filing and a prior 'going concern' warning reveal deep financial turmoil at the specialty coffee innovator, raising questions about its future.

As Nasdaq threatens delisting, Hub Group's $870M meltdown reveals more than accounting errors—it's a stark lesson in corporate governance.

uCloudlink's stock is below $1, triggering a Nasdaq delisting threat. Is this a market blip or a fatal sign that its 'data sharing' dream is fading?

Republic Technologies is trading again after a costly regulatory halt. While its shares bounce, a deeper dive into its finances reveals the hidden risks.

AGCO's stock plunged after a surprise guidance cut, triggering a legal probe. We dissect if this was just a market downturn or a failure in transparency.

An AI-driven biodefense firm is using anti-racketeering laws to fight alleged market fraud. Is this a landmark battle for market integrity?

A securities fraud lawsuit hits battery maker Microvast, alleging a pattern of false statements. We dissect the short-seller report, CFO exit, and missed targets.

Hong Kong-based Fenbo Holdings has 180 days to save its Nasdaq listing. Its sub-$1 stock price reveals deeper issues in manufacturing and global markets.

As Hyperion DeFi (HYPD) preps its Q2 report, the market awaits a first look into the viability of a publicly-traded company built on a DeFi protocol.

A 49% stock plunge and a major acquisition write-down have thrust GeneDx into legal turmoil. We deconstruct the securities fraud claims and what they reveal.

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

A class-action lawsuit against Futu Holdings exposes the severe risks of China's regulatory crackdown on tech, leaving investors to navigate the fallout.

Facing delisting pressure, gold miner Blue Gold is deploying a high-stakes playbook. But is its struggle a company-specific issue or a warning for all small-caps?

A major logistics firm faces a crisis of confidence as a shareholder lawsuit exposes years of misstated financials and systemic control failures.